Training activity information
Details
Select the correct genetic tests for patients referred with acquired haematological malignancies, to include:
- AML
- ALL
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Role of genetic testing in the diagnosis of leukaemia
- Sample acceptance criteria
- Sample transport and storage
- Reason for referral – diagnosis, prognosis, treatment, monitoring, MRD, transplantation and chimerism
- Sample types – use and limitations of sample types, including bone marrow and peripheral blood
- Testing pathways
- Local SOPs
- Health and safety
- Consent process for minors
- Onward referrals
- Precision medicine
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 1 |
Outcome
Apply appropriate sample selection criteria for the commonly referred cancer samples, taking into account the implications of the referral with respect to sample type, sampling mixed cell populations, limits of detection, sensitivity of assay and patient management. |
| # 2 |
Outcome
Select the laboratory testing strategy for the commonly referred cancer samples at all stages of the patient pathway. |